Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Oncotarget|February 19, 2019
Poor overall survival in hyperhaploid multiple myeloma is defined by double-hit bi-allelic inactivation of <i>TP53</i>Cody Ashby, Ruslana G Tytarenko, Yan Wang, et al.
Haematologica|May 28, 2017
The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myelomaAneta Mikulasova, Christopher P Wardell, Alexander Murison, et al.
Genes, Chromosomes & Cancer|October 1, 2011
The clinical impact and molecular biology of del(17p) in multiple myeloma treated with conventional or thalidomide-based therapyKevin D Boyd, Fiona M Ross, William J Tapper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2018
HSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic TargetJacqueline H L Fok, Somaieh Hedayat, Lei Zhang, et al.
Leukemia|July 3, 2013
Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptomsBrian A Walker, Christopher P Wardell, Lorenzo Melchor, et al.
Blood|November 28, 2014
Coexistent hyperdiploidy does not abrogate poor prognosis in myeloma with adverse cytogenetics and may precede IGH translocationsCharlotte Pawlyn, Lorenzo Melchor, Alex Murison, et al.
Leukemia|August 8, 2021
Plasma cells expression from smouldering myeloma to myeloma reveals the importance of the PRC2 complex, cell cycle progression, and the divergent evolutionary pathways within the different molecular subgroupsEileen M Boyle, Adam Rosenthal, Hussein Ghamlouch, et al.
Genes, Chromosomes & Cancer|October 8, 2014
A molecular diagnostic approach able to detect the recurrent genetic prognostic factors typical of presenting myelomaEileen M Boyle, Paula Z Proszek, Martin F Kaiser, et al.
Haematologica|June 22, 2019
Microhomology-mediated end joining drives complex rearrangements and overexpression of <i>MYC</i> and <i>PVT1</i> in multiple myelomaAneta Mikulasova, Cody Ashby, Ruslana G Tytarenko, et al.
Nature Communications|January 13, 2021
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myelomaEileen M Boyle, Shayu Deshpande, Ruslana Tytarenko, et al.
Pageof 5